Core Viewpoint - Almaden Minerals Ltd. has established a Key Persons Retention Agreement (KPA) to retain key personnel essential for its international arbitration proceedings under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership with Mexico [1][2]. Group 1: Key Persons Retention Agreement (KPA) - The KPA is designed to ensure the active participation of key personnel, who are crucial for the Claim process, and they must fulfill specific duties to be entitled to a percentage of the proceeds [2]. - If the Claim is successful, 4.0% of the net proceeds will be allocated to the KPA for distribution among key personnel, specifically Korm Trieu (CFO) and Douglas McDonald (Executive Vice President) [3]. - The maximum aggregate amount payable under the KPA is set at US$12 million, which does not reflect the Company's view on the merits of the Claim [3]. Group 2: Approval and Fairness - The KPA will be presented for approval at the upcoming Annual General and Special Meeting of Shareholders on June 26, 2025, with full details included in the management information circular [4]. - A third-party financial advisory firm, Evans & Evans, Inc., has confirmed that the terms of the KPA are fair and reasonable from a financial standpoint for the Company's shareholders [5].

Core Insights - Solitron Devices, Inc. reported its fiscal 2025 fourth quarter and full year results, highlighting both challenges and opportunities in its operations [1] Fiscal 2025 Fourth Quarter Highlights - Revenue for the fourth quarter was $3.13 million, a decrease of 22% compared to $4.00 million in the same quarter of fiscal 2024 [5][8] - Net bookings increased significantly by 301% to $8.92 million from $2.23 million in the fourth quarter of fiscal 2024 [8] - The backlog rose by 62% to $18.11 million at the end of the fourth quarter compared to $11.21 million at the end of the fourth quarter of fiscal 2024 [8] - The company reported a net loss of $0.37 million, or $0.18 per share, contrasting with a net income of $5.80 million, or $2.78 per share, in the fourth quarter of fiscal 2024 [8] Fiscal Year 2025 Highlights - For the full fiscal year 2025, net sales increased by 10% to approximately $14.05 million from $12.76 million in fiscal year 2024 [8] - Net bookings for the year rose by 62% to $20.76 million compared to $12.84 million in fiscal year 2024 [8] - The backlog at the end of fiscal year 2025 was $18.11 million, up 62% from $11.21 million at the end of fiscal year 2024 [8] - Net income for fiscal year 2025 decreased to $0.82 million, or $0.39 per share, from $5.80 million, or $2.78 per share, in fiscal year 2024, which had benefited from non-recurring events [8] Market and Product Development - The company experienced substantial bookings related to major defense programs, with expectations for future production levels to increase, particularly for the AMRAAM and HIMARS programs [4] - There is a growing interest in new product development, including silicon carbide, with various prototypes being tested for potential customers [6]

Core Viewpoint - Magnetic North Acquisition Corp. is currently under a management cease trade order due to its inability to file audited annual financial statements for the year ended December 31, 2024, by the required deadline of April 30, 2025, but expects to file these documents by June 30, 2025 [1][2]. Group 1 - The management cease trade order (MCTO) was granted by the Alberta Securities Commission on May 9, 2025, following the company's default announcement on May 8, 2025 [1]. - The company confirms it will continue to satisfy the alternative information guidelines under NP 12-203 and will issue bi-weekly default status reports until the filing delay is resolved [2]. - There are no insolvency proceedings against the company, and no material undisclosed information regarding its affairs exists [2]. Group 2 - Magnetic North Acquisition Corp. invests and manages businesses on behalf of its shareholders, emphasizing that capital alone does not guarantee success [3]. - The company operates offices in Calgary and Toronto and has a management team with significant expertise in management, operations, and capital markets [3]. - Magnetic North's common and preferred shares are traded on the TSX Venture Exchange under the symbols MNC and MNC.PR.A, respectively, and it was recognized as a "2021 TSX Venture 50" recipient [3].

Core Viewpoint - Captivision Inc. is currently facing compliance issues with Nasdaq due to the failure to file its Annual Report on Form 20-F for the year ended December 31, 2024, which may affect its listing status if not resolved [1][2][3] Group 1: Compliance Issues - The Company received a notification from Nasdaq stating it is not in compliance with Listing Rule 5250(c)(1) due to the unfiled Form 20-F [1] - Captivision has 60 calendar days, until July 21, 2025, to submit a plan to regain compliance, with a potential extension of up to 180 days if accepted [2] - The Company is actively working to finalize and file the Form 20-F within the prescribed timeline but cannot guarantee compliance within the cure period [3] Group 2: Company Overview - Captivision is a manufacturer of media glass that integrates IT building materials with architectural glass, applicable in various sectors including entertainment and marketing [4] - The Company's media glass solutions have been implemented in numerous global locations such as sports stadiums, casinos, and airports [5]

Group 1 - Viomi Technology Co., Ltd has received a Delinquency Letter from NASDAQ for not timely filing its annual report for the fiscal year ended December 31, 2024 [1][2] - The Company has 60 calendar days to submit a Compliance Plan to regain compliance with NASDAQ Listing Rules, with a potential extension until November 11, 2025 if accepted [2] - The Delinquency Letter does not have an immediate impact on the listing of the Company's ordinary shares on the Nasdaq Capital Market [3] Group 2 - Viomi is a leading technology company in home water solutions, focusing on AI technology to improve drinking water quality [4][5] - The Company operates a unique "Equipment + Consumables" business model, enhancing filter replacement rates and promoting the adoption of water purifiers [5] - Viomi's "Water Purifier Gigafactory" supports an integrated industrial chain, achieving economies of scale and facilitating advancements in water purification technology [5]

PHOENIX, May 23, 2025 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE: VATE), announced today that it will pay a cash dividend of approximately $5.5 million, or $1.42 per share, on June 16, 2025 to DBMG’s stockholders of record at the close of business on June 2, 2025. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients through a highly ...

Core Viewpoint - Plus Therapeutics, Inc. has received a delinquency notification from Nasdaq due to the delayed filing of its Quarterly Report for the period ended March 31, 2025, but this does not immediately affect its listing status on Nasdaq [1][2]. Group 1: Compliance and Filing Status - The Company must submit a plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) by July 21, 2025 [2]. - If the compliance plan is accepted, Nasdaq may grant an extension of up to 180 calendar days, allowing the Company until November 17, 2025, to regain compliance [2]. - The Company is actively working to file the Quarterly Report as soon as possible and aims to return to a normal filing schedule for the remainder of 2025 [2]. Group 2: Company Overview - Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company based in Houston, Texas, focused on developing targeted radiotherapeutics for challenging cancers of the central nervous system [3]. - The Company employs a combination of image-guided local beta radiation and targeted drug delivery methods, with key programs targeting leptomeningeal metastases and recurrent glioblastoma [3]. - Plus Therapeutics has established a supply chain through strategic partnerships to support the development, manufacturing, and potential commercialization of its products [3].

Raanana, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), stating that based on its review of the Company’s public filings with the Securities and Exchange Commission (the “SEC”), its staff has determined to delist ...

Core Points - INNOVATE Corp. announced that its subsidiary DBM Global Inc. will pay a cash dividend of approximately $5.5 million, or $1.42 per share, to stockholders on June 16, 2025 [1] - As the largest stockholder of DBMG, INNOVATE expects to receive around $5 million from the total dividend payout [1] - Individual stockholders of INNOVATE are not eligible to receive the cash dividend [1] Company Overview - INNOVATE Corp. operates in three key areas of the new economy: Infrastructure, Life Sciences, and Spectrum, employing approximately 3,100 people across its subsidiaries [2] - DBM Global Inc. focuses on delivering sustainable value through integrated steel construction services and professional services, with operations in multiple countries including the United States, Australia, Canada, India, New Zealand, the Philippines, and the United Kingdom [3]

Miami, Florida, May 23, 2025 (GLOBE NEWSWIRE) -- Oyster Enterprises II Acquisition Corp (the “Company”) (Nasdaq: OYSEU) announced today the closing of its upsized initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000. The Company’s units began trading on May 22, 2025 on the Nasdaq Global Market (“Nasdaq”) under ...